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Brief Communications
Mitogen-Activated Protein Kinase Phosphatase-2 Deletion
Impairs Synaptic Plasticity and Hippocampal-Dependent
Memory
Nor Zaihana Abdul Rahman,1 Sam M. Greenwood,1 Ros R. Brett,1 Kyoko Tossell,2 X Mark A. Ungless,2 Robin Plevin,1
and X Trevor J. Bushell1
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, United Kingdom, and 2Medical Research Council
Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom
Mitogen-activated protein kinases (MAPKs) regulate brain function and their dysfunction is implicated in a number of brain
disorders, including Alzheimer’s disease. Thus, there is great interest in understanding the signaling systems that control MAPK
function. One family of proteins that contribute to this process, the mitogen-activated protein kinase phosphatases (MKPs),
directly inactivate MAPKs through dephosphorylation. Recent studies have identified novel functions of MKPs in development,
the immune system, and cancer. However, a significant gap in our knowledge remains in relation to their role in brain functioning.
Here, using transgenic mice where the Dusp4 gene encoding MKP-2 has been knocked out (MKP-2 / mice), we show that
long-term potentiation is impaired in MKP-2 / mice compared with MKP-2 / controls whereas neuronal excitability, evoked
synaptic transmission, and paired-pulse facilitation remain unaltered. Furthermore, spontaneous EPSC (sEPSC) frequency was
increased in acute slices and primary hippocampal cultures prepared from MKP-2 / mice with no effect on EPSC amplitude
observed. An increase in synapse number was evident in primary hippocampal cultures, which may account for the increase in
sEPSC frequency. In addition, no change in ERK activity was detected in both brain tissue and primary hippocampal cultures,
suggesting that the effects of MKP-2 deletion were MAPK independent. Consistent with these alterations in hippocampal function,
MKP-2 / mice show deficits in spatial reference and working memory when investigated using the Morris water maze. These data
show that MKP-2 plays a role in regulating hippocampal function and that this effect may be independent of MAPK signaling.
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Introduction
Cellular maintenance and survival is dependent on multiple
cell signaling pathways, including mitogen-activated protein
kinase (MAPK) signaling. The MAPK family consists of
the extracellular signal-related kinase (ERK), the c-jun
N-terminal kinase (JNK), and p38 MAPK (Cuevas et al., 2007;
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Significance Statement
Recently, there has been significant focus on proteins that control mitogen-activated protein kinases’ (MAPKs) function,
namely the mitogen-activated protein kinase phosphatases (MKPs). Recent studies have revealed novel roles for a specific
MKP, MKP-2, in the immune system and cancer. In the present study, we focus on MKP-2 to determine its role in neuronal
function. Using transgenic mice where the Dusp4 gene encoding MKP-2 has been knocked out, we use a number of tech-
niques to reveal that MKP-2 deletion increases spontaneous neurotransmitter release, impairs the induction of synaptic
plasticity, and induces deficits in hippocampal-dependent memory. These findings provide a new insight into role that
MKP-2 plays in regulation hippocampal function and that this may be independent of MAPK signaling.
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Keshet and Seger, 2010). MAPK proteins are expressed in nu-
merous cell types within the CNS where they play an impor-
tant role in the regulation of synaptic transmission and
plasticity (Thomas and Huganir, 2004; Samuels et al., 2009).
In addition, MAPKs have a role in modulating learning and
memory (Ciccarelli and Giustetto, 2014) and their dysfunc-
tion has also been implicated in a range of CNS disorders
including Alzheimer’s disease, multiple sclerosis, and Parkin-
son’s disease (Samuels et al., 2009; Yasuda et al., 2011; Kre-
mentsov et al., 2013).
The kinetics of MAPK signaling are directly regulated
through the activation and/or expression of a family of dual-
specificity phosphatases (DUSPs), the mitogen-activated pro-
tein kinase phosphatases (MKPs), that dephosphorylate
MAPKs and thus inhibit their activity (Caunt and Keyse,
2013). MKPs have recently been shown to play key roles in
development, immunity, and cancer (Lawan et al., 2012;
Wancket et al., 2012). However, our knowledge regarding
MKP function in the brain is extremely limited. Although
studies support a role for the prototypic MKP, Dusp1 (MKP-
1), in axonal branching (Jeanneteau et al., 2010) and depres-
sion (Duric et al., 2010), the potential role of Dusp4 (MKP-2)
function in the CNS has been largely neglected. To elucidate
the potential role of MKP-2 in brain function, given the absence of
specific MKP-2 inhibitors, here we assess hippocampal neuronal
excitability and synaptic plasticity and hippocampal-dependent be-
havior in MKP-2/ mice.
Materials and Methods
Animals
Heterozygote MKP-2 mice backcrossed on a C57BL/6J background
generated homozygous and wild-type littermates that were used for
breeding colonies (Al-Mutairi et al., 2010). All breeding and experi-
mentation were in accordance with UK legislation [Animals (Scien-
tific Procedures) Act 1986] and with approval by the University of
Strathclyde Ethics Committee.
Tissue preparation
Primary hippocampal cultures were prepared and maintained from 1- to
2-d-old MKP-2 / or MKP-2 / pups as described previously (Gan et
al., 2011). Parasagittal hippocampal slices (400 m) were prepared from
male mice (19- to 24-d-old) as previously described (Gan et al., 2011)
with slices initially incubated at 35°C for 30 min, and then allowed to
equilibrate for 1 h at room temperature before use.
Electrophysiology
Cultured neurones. Hippocampal cultures were perfused at a flow rate at
1–2 ml min 1 with HEPES-buffered saline composed of the following
(in mM): NaCl 140, KCl 5, MgCl2 2, CaCl2 2, HEPES 10, D-glucose 10, pH
7.4, 310 mOsm. Fire-polished glass microelectrodes (3–5 M) were filled
with intracellular solution containing the following (in mM): KMeSO4
130, KCl 20, Mg-ATP 4, Na-GTP 0.3, EGTA 0.3, HEPES 10, pH 7.2, 290
mOsm. sEPSCs were recorded at 70 mV for 5 min periods at room
temperature in voltage-clamp mode using WinEDR software (J. Demp-
ster, University of Strathclyde, UK), digitized at 5 kHz, and analyzed
off-line using Mini analysis software (Synaptosoft). All experiments were
performed on at least three independent cultures.
Acute slices. Slices were transferred into a submerged recording cham-
ber maintained at 30°C and continuously perfused with oxygenated
ACSF at a flow rate at 2–3 ml min 1. Electrodes (4 –7 M) were filled
with an internal solution containing the following (in mM): 130 Cs/K
MeSO4, 8 NaCl, 4 Mg-ATP, 0.3 Na-GTP, 0.5 EGTA, 10 HEPES, pH 7.2,
290 mOsm. Whole-cell patch-clamp recordings were made from CA1
pyramidal neurons using WinWCP or WinEDR software (J. Dempster,
University of Strathclyde, UK). For current–voltage relationships (K 
internal), current injections at 10 s intervals was used. For synaptic trans-
mission (Cs  internal), the Schaffer collateral– commissural pathway
was stimulated with a bipolar electrode (0.033 Hz) with responses set to
50% of maximum. For paired-pulse facilitation (PPF) experiments, in-
terstimulus intervals (ISI, 50 –500 ms) were used with long-term poten-
tiation (LTP) being induced using a pairing protocol (100 stimuli, 1 Hz,
VH  0 mV) with data digitized at 10 kHz and analyzed off-line using
WinWCP. sEPSCs were recorded at 70 mV for 5 min periods using
WinEDR, digitized at 5 kHz, and analyzed off-line using Mini analysis
software (Synaptosoft). For all slice experiments, n is equal to one slice
per animal with the experimenter being blind to genotype.
Immunostaining
Cultures. Cultures were fixed in ice-cold 4% paraformaldehyde (PFA; 10
min) followed by ice-cold methanol (100%, 10 min), and then perme-
abilized with 0.01% Triton-X (in PBS, 10 min), followed by incubation in
a blocking solution [5% fetal bovine serum, 1% bovine serum albumin
(BSA) in PBS, 1 h]. Primary antibodies [anti-III-tubulin (1:500),
Sigma-Aldrich no. T8578; anti-synaptophysin (1:500), Millipore no.
MAB368; pERK (1:500) Cell Signaling Technology no. 9106; total ERK
(1:500), Santa Cruz Biotechnology no. sc-514302] were applied directly
to the coverslip and incubated overnight at 4°C. Cultures were then
washed and incubated (1 h) with the appropriate fluorescent secondary
antibody (1:200, AlexaFluor 488 no. A10538, AlexaFluor 555 no.
A-31572, Life Sciences) diluted in blocking buffer. Cultures were then
washed and images acquired using epifluorescent microscopy. Syn-
apse number and fluorescent intensity was measured using NIH
ImageJ software with all data analyzed from at least three separate
cultures.
Slices. Male mice (10- to 12-weeks-old) were perfused transcardially
with 4% PFA. Brains were removed and postfixed in 4% PFA (1 h),
washed with PBS, and followed by cryoprotection in 30% sucrose.
Coronal brain slices (70 m) were prepared using a cryostat (Leica).
Slices were rinsed with PBS and agitated in PBS with 0.5% Triton
X-100 (15 min). Free-floating slices were then pre-blocked (1 h) at
room temperature in PBS with 0.2% Triton X-100, 6% normal don-
key serum (NDS; Jackson ImmunoResearch), and incubated over-
night at 4°C with mouse monoclonal NeuN antibody (1:1000, Abcam
no. ab104224) with 0.2% Triton X-100 and 2% NDS. Slices were
rinsed in PBS (1 h) and incubated (2 h) with donkey anti-mouse Cy3
(1:1000, Jackson ImmunoResearch, no. 715-165-150) and DAPI (1:
1000, Santa Cruz Biotechnology) with 2% Triton X-100 and 2% NDS.
After subsequent PBS rinses, slices were mounted on slides using
Fluoromount Aqueous Mounting Medium (Sigma-Aldrich) and vi-
sualized using a Leica SP5 confocal laser-scanning microscope.
Western blot
Total protein from the cerebellum, cortex and hippocampus from
male mice (19- to 24-d-old) was used for Western blot analysis.
Briefly, protein samples (10 g) were loaded in 10% SDS polyacryl-
amide gels, subjected to electrophoresis, and blotted onto a nitrocel-
lulose sheet with nonspecific binding was blocked using a NaTT
buffer containing 4% BSA (2 h). Blots were then incubated overnight
with specific primary antibodies for p-ERK (1:500, Santa Cruz
Biotechnology, no. sc-32577) prepared in 0.4% BSA/NaTT, washed
with NaTT buffer before incubating with horse-radish peroxidase-
conjugated anti-mouse IgG secondary antibody (1.5 h). Blots were
then washed (2 h) and developed. After detection of phosphor-
specific bands, blots were stripped and re-probed with total ERK
antibody (1:500, Santa Cruz Biotechnology, no. sc-514302). Bands
were quantified using densitometry with Scion Image software with
values expressed as percentage of p-ERK over total ERK.
Behavioral testing
MKP-2 / and MKP-2 / mice (n  22–24) were tested in the follow-
ing order: open field test (OF), elevated plus-maze (EPM), and Morris
water maze (MWM) with mice videoed and tracked by Ethovision soft-
ware (Noldus).
OF: distance moved in a 40-cm-square open field, and center
square (14 cm) entries and time were recorded for 10 min. EPM: the
number of open and closed arm entries during 10 min in a plus-
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shaped maze with two open (30  5 cm) and two closed arms (30  5
cm, 15 cm walls) elevated 70 cm from the floor were recorded and
percentage open arm entries and time calculated. MWM: mice were
tested in a 98-cm-diameter maze containing water at 21°C with a
transparent 10-cm-diameter submerged platform, in a room with
extra-maze cues. Reference memory: three to four times daily for 5 d,
mice were released at one of four randomly varied points and swam
until they located the platform. Platform location remained constant
for each mouse. Path-length and latency to reach the platform were
calculated as the mean of each day’s trials. On the final trial of day 5,
the platform was removed and mice allowed to swim for 60 s (probe
test). Time spent in the quadrant of the previous location of the
Figure 1. Increased sEPSC frequency but normal neuronal excitability and synaptic transmission in MKP-2 / hippocampal slices. a, b, Representative traces from MKP-2 / and MKP-2 /
slices respectively. c, No alteration in AP firing or (d) evoked transmission in MKP-2 / slices. e, f, Representative sEPSC traces from MKP-2 / and MKP-2 / slices respectively. g, Increased
sEPSC frequency is evident in MKP-2 / slices, whereas (h) sEPSC amplitude is unaltered. *p  0.05.
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platform (target quadrant) and the opposite quadrant was recorded.
Working memory: 3 d later, mice were tested with a daily changing
platform position (7 cm platform to increase difficulty) for 3 d. Each
day, mice were allowed up to seven trials and given a score equaling
the number of trials to reach criterion (successful location in 10 s
twice consecutively). If criterion was not reached by the seventh trial,
a score of 8 was given if it would be possible to reach criterion on the
next trial, otherwise a score of 9.
Figure 2. Increased sEPSC frequency in MKP-2 / cultures but impaired LTP in MKP-2 / slices. a, b, Representative traces of sEPSCs in MKP-2 / and MKP-2 / mice cultures (11 DIV)
respectively. c, d, Increased sEPSC frequency but not amplitude in 11 DIV MKP-2 / primary hippocampal cultures. e, f, Increased sEPSC frequency but not amplitude in 7 DIV MKP-2 / primary
hippocampal cultures. g, PPF is unaltered in MKP-2 / slices, whereas (h) LTP is impaired compared with MKP-2 / controls. *p  0.05.
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Statistics
All data are expressed as mean  SEM. Data were
compared by paired or unpaired Student’s t tests,
one-way ANOVA with Tukey’s comparison, or
two-way mixed-model ANOVA followed by
Bonferroni post hoc comparisons as appropriate.
Differences were considered significant when p
0.05.
Results
Hippocampal neuronal excitability and
evoked synaptic transmission are
unaltered in MKP-2 / mice
Action potential firing in response to cur-
rent injection (Fig. 1a–c), resting mem-
brane potential (MKP-2/: 68  1
mV, n  5; MKP-2/: 67  1 mV, n 
6) and input resistance (MKP-2/:
131  6 M, n  5; MKP-2/: 130  5
m, n  6) were unaltered in slices from
MKP-2/ mice compared with MKP-
2/ controls. Similarly, evoked synaptic
transmission was unaffected by MKP-2
deletion (Fig. 1d) as was the modulation
of synaptic transmission by MAPK path-
way inhibitors. Indeed, U0126 (40 M)
and SP600125 (20 M), inhibitors of
ERK and JNK, respectively, were without
effect on basal synaptic transmission in
both MKP-2/ and MKP-2/ slices,
whereas the p38 MAPK inhibitor,
SB203580 (100 M) significantly in-
creased basal synaptic transmission to a
similar extent in MKP-2/ and MKP-
2/ slices (MKP-2/: 52  22% in-
crease, n  8, MKP-2/: 51  8%
increase, n  5).
MKP-2 deletion results in increased sEPSC frequency
With no effect of MKP-2 deletion on neuronal excitability and
evoked synaptic transmission, we investigated whether MKP-2
played a role in modulating spontaneous neurotransmitter
release. sEPSC frequency, but not amplitude, was significantly
increased in MKP-2/ hippocampal slices compared with
MKP-2/ (p  0.05; Fig. 1e–h). This was also present in pri-
mary hippocampal cultures prepared from MKP-2/ and
MKP-2/ mice. At 11 d in vitro (DIV), the frequency of sEPSCs,
but not amplitude was significantly increased in MKP-2/ cul-
tures compared with MKP-2/ cultures (p  0.05; Fig. 2a–d).
Similarly, at 7 DIV, when little evidence of synaptic activity was
observed in MKP-2/ cultures, the frequency of sEPSCs was
significantly increased in MKP-2/ cultures with no difference
in sEPSC amplitude detected (p  0.05; Fig. 2e,f).
Impaired LTP but normal PPF in MKP-2 / mice
Having investigated synaptic transmission, we next examined the
role of MKP-2 in modulating hippocampal short-term and long-
term plasticity. PPF (50 –500 ms ISI) was unchanged between
MKP-2/ and MKP-2/ slices (Fig. 2g). Similarly, short-term
potentiation was unchanged following LTP induction (p 	 0.05;
Fig. 2h), whereas there was a significant impairment in the main-
tenance of LTP, with EPSC amplitude returning to baseline
within 30 min of induction in MKP-2/ slices while LTP was
maintained in MKP-2/ slices (p  0.01; Fig. 2h).
MKP-2 deletion increases synapse number but ERK activity
is unaffected
An interpretation of our sEPSC data are a change in presynaptic
function but no change in PPF suggests that probability of release
in unchanged. An alternative explanation for increased sEPSC
frequency is an increased synapse number. Hence, we investi-
gated synapse number using the synaptic marker, synaptophysin
in 7 and 11 DIV cultures. Synapse number was significantly in-
creased at both 7 and 11 DIV in MKP-2/ cultures compared
with MKP-2/ cultures (p  0.001; Fig. 3a,b). We further ex-
amined whether hippocampal structure or altered ERK activity
contributed to this observation. Brain size and hippocampal
structure were unaltered in MKP-2/ mice compared with
MKP-2/ controls when examined using immunolabeling for
NeuN (Fig. 3c). In addition, there were no significant differences
in phospho-ERK levels in the hippocampus, the cortex, or the
cerebellum (Fig. 3d), respectively, with no change in total ERK
being observed in any of these brain regions. In addition, no
change in ERK activity was seen at both 7 DIV (MKP-2/: 69 
5% of total ERK, MKP-2/: 75  6% of total ERK, p 	 0.05)
and 11 DIV cultures (MKP-2/: 86  7% of total ERK, MKP-
2/: 91  4% of total ERK, p 	 0.05).
Impaired spatial reference and working memory in
MKP-2 / mice
Having established alterations in hippocampal synaptic plastic-
ity, we probed hippocampal-dependent memory processes of
MKP-2/ mice using the MWM. Although MKP-2/ mice
revealed no changes in the OFT or EPM (Fig. 4a,b), on the first
Figure 3. Increased synapse number in MKP-2 / hippocampal cultures. a, Representative images and (b) bar chart sum-
marizing the increased synapse number in MKP-2 / hippocampal cultures. c, Hippocampal structure and (d) ERK activity is
unaltered in MKP-2 / mice. ***p  0.001. Scale bars: a, 10 m; c, 100 m.
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day of testing, the path-length to platform was significantly in-
creased in MKP-2/ mice (p  0.05; Fig. 4c). However, on
subsequent trial days (days 2– 4) there was no significant differ-
ence between the two genotypes. Furthermore, although all ani-
mals learnt the position of the platform, as evidenced by a
significant decrease in path-length to locate the platform and
latency to platform (Fig. 4c,d), and by the observation that all
mice spent significantly more time in the target quadrant than in
the opposite quadrant during the probe trial (Fig. 4e), this was
not significantly different between the two genotypes. However,
in a subsequent 3 d working memory paradigm, MKP-2/ mice
required significantly more trials to achieve criterion (p  0.05;
Fig. 4f) than MKP-2/ mice.
Discussion
In the absence of specific MKP-2 inhibi-
tors, we have used MKP-2/ mice to
probe the function of MKP-2 in the CNS.
We have shown that MKP-2 deletion
results in increased sEPSC frequency
and impaired hippocampal LTP in the
absence of any deleterious effect on
neuronal excitability, evoked synaptic
transmission, or short-term plasticity.
Furthermore, an increased synapse num-
ber was observed but no alternation in
ERK activity was evident. Finally, whereas
locomotor activity and anxiety-like be-
havior are unaltered in MKP-2/ mice,
hippocampal-dependent memory pro-
cesses were impaired.
A significant increase in sEPSC fre-
quency, but not amplitude, with no overt
effect on evoked synaptic transmission or
PPF implies that vesicle release probabil-
ity is unaffected as alterations would
be expected in both sEPSC frequency
and PPF if this were involved. MAPKs
modulate release machinery and conse-
quently neurotransmitter release with for
example, ERK-dependent phosphoryla-
tion of synapsin 1 leading to an increase in
docked vesicles, mEPSC frequency and
PPF (Kushner et al., 2005; Giachello et al.,
2010). The increase in sEPSCs we observe
is consistent with these findings. How-
ever, given the observed lack of effect on
PPF and ERK activity, it may be an alter-
native mechanism entirely that is in-
volved. Indeed, an increase in synapse
number in hippocampal MKP-2/ cul-
tures was seen that could account for the
increased sEPSC frequency. This is in
agreement with previous studies which
have revealed that neurotransmitter re-
lease modulation but not PPF is a result of
synapse number rather than changes in
release probability (McClelland et al.,
2010; Guimond et al., 2014). However, it
should be noted that we examined only
spontaneous excitatory neurotransmitter
release whereas synaptophysin identifies
all synapses so this increase in number
may also include an increase in inhibitory
synapses, hence we cannot rule out a role for MKP-2 in inhibitory
transmission. Similarly, although we focused on ERK activity in
the present study, this does not rule out a role of other MAPKs.
However, whether an increase in synapse number alone underlies
our observations would require examination of other potential
mechanisms including localized presynaptic changes in MAPK
activity and/or an increase in the number of docked vesicles.
Despite no change in short-term plasticity, LTP was impaired in
MKP-2/ slices. The requirement for ERK in the induction and
maintenance of LTP in mouse brain slices is dependent on the
induction protocol used with previous studies indicating that the
protocol used here would be ERK independent (Sweatt, 2004).
Figure 4. Impaired spatial reference and working memory in MKP-2 / mice. a, General locomotor activity is unaltered in
MKP-2 / mice as measured in the OFT. b, Anxiety-like behavior is normal in MKP-2 / mice as measured in the EPM. c,
Path-length to platform is significantly longer in MKP-2 / mice, whereas (d) latency to the hidden platform in MWM reference
memory paradigm is unchanged. e, Both genotypes learnt the location of the platform over 4 d of the MWM (f ) trials to criterion
is significantly higher in MKP-2 / mice over 3 consecutive days of a MWM working memory paradigm. *p  0.05 versus
MKP-2 / controls; #p  0.05 target versus opposite quadrant.
Abdul Rahman et al. • MKP-2 Deletion Impairs Hippocampal Function J. Neurosci., February 24, 2016 • 36(8):2348 –2354 • 2353
Given that ERK activity was unchanged in our preparations, this
may indicate that ERK plays no role in the impaired LTP ob-
served here but whether changes in LTP would be observed using
alternative ERK-dependent induction protocols remains unclear.
However, a link between spontaneous neurotransmitter release
and synaptic plasticity may indicate that the increased sEPSC
plays a role in the impaired LTP seen here. Spontaneous neu-
rotransmitter release is regulated by various neuromodulators
(Kavalali, 2015) but recent studies indicate it also plays a critical
role in synaptic scaling. Indeed, it is proposed that spontaneous
neurotransmitter release regulates the expression of postsynaptic
NMDA receptor subunit composition (Lee et al., 2010) and se-
lective inhibition of spontaneous NMDA-mediated neurotrans-
mission potentiates hippocampal synaptic responses (Nosyreva
et al., 2013). Hence, given the increased sEPSC frequency ob-
served in the present study, this implies that this increased syn-
aptic activity reduces the ability of these synapses to exhibit LTP.
However, whether changes in NMDA receptor subunit compo-
sition account for this observation is beyond the scope of this
study but our data indicates it warrants further investigation us-
ing, for example, NMDA/AMPA ratio analyses.
As LTP is proposed to be a molecular correlate of memory,
our data indicating deficits in hippocampal-dependent memory
processes in MKP-2/ mice supports this view. Numerous
studies have reported that both genetic and pharmacologic ma-
nipulation of hippocampal activity results in impaired LTP in
vitro and performance in hippocampal-dependent memory pro-
cesses in vivo but as to whether one does indeed underlie the other
remains an area of intense debate (Takeuchi et al., 2013). How-
ever, our data revealing impaired spatial reference memory on
the initial trial day and reduced performance in a subsequent
working memory paradigm strongly indicates that the observed
changes in synaptic function do indeed correlate with the ob-
served behavioral deficits. In addition, it would be interesting to
extrapolate these hippocampal findings to determine whether
other brain regions associated with working memory including
the prefrontal cortex, also exhibit similar alterations in synaptic
activity and plasticity.
Together, these novel data indicate that MKP-2 plays a signif-
icant role in hippocampal synaptic function, with a particular
locus being spontaneous rather than evoked neurotransmitter
release. Further studies are required to fully examine the role of
MKP-2 in normal brain functioning and in CNS disorders, par-
ticularly those in which memory deficits are prominent.
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